Lab Reagents
Human IgG antibody Laboratories manufactures the spike protein sequence reagents distributed by Genprice. The Spike Protein Sequence reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Spike products are available in stock. Specificity: Spike Category: Protein Group: Sequence
Sequence information
Anantin (linear sequence) |
5-00672 |
CHI Scientific |
4 x 1mg |
Ask for price |
C5a Inhibitory Sequence |
H-8135.0005 |
Bachem |
5.0mg |
EUR 849.6 |
Description: Sum Formula: C51H86N12O9; CAS# [133214-60-5] |
C5a Inhibitory Sequence |
H-8135.0025 |
Bachem |
25.0mg |
EUR 3286.8 |
Description: Sum Formula: C51H86N12O9; CAS# [133214-60-5] |
Anantin (linear sequence) |
H-8140.0001 |
Bachem |
1.0mg |
EUR 691.2 |
Description: Sum Formula: C90H113N21O25; CAS# [348600-37-3] net |
Anantin (linear sequence) |
H-8140.0005 |
Bachem |
5.0mg |
EUR 2648.4 |
Description: Sum Formula: C90H113N21O25; CAS# [348600-37-3] net |
SARS Biotinylated Spike RBD Recombinant Protein |
10-212 |
ProSci |
0.1 mg |
EUR 752.1 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Sars-Cov, Spike (Middle) Recom Protein |
abx060656-1mg |
Abbexa |
1 mg |
EUR 2030.4 |
|
SARS Associated Spike Mosaic S Protein |
20-abx260156 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1646.40
|
|
|
Anti-MERSC-CoV Spike Protein antibody |
STJ140102 |
St John's Laboratory |
150 µg |
EUR 277.2 |
Description: Goat polyclonal to Spike protein of Middle East respiratory Syndrome coronavirus. Coronaviruses access host cells by membrane fusion, a process mediated by specific fusion or “spike” proteins on the virion, often activated by cellular proteases. |
Recombinant SARS Spike gp C Protein |
VAng-Lsx0072-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: SARS Spike glycoprotein C, recombinant protein from E. coli. |
SARS-CoV Spike Antibody |
3219-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
3219-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
3221-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |